The Journal of Allergy and Clinical Immunology
Volume 122, Issue 4 , Pages 734-740 , October 2008

Steroids completely reverse albuterol-induced β2-adrenergic receptor tolerance in human small airways

  • Philip R. Cooper, PhD
  • ,
  • Reynold A. Panettieri Jr., MD

      Affiliations

    • Corresponding Author InformationReprint requests: Reynold A. Panettieri, Jr, MD, Airways Biology Initiative TRL, Suite 1200, 125 South 31st St, Philadelphia, PA 19104.

Received 17 March 2008 ,Revised 28 July 2008 ,Accepted 30 July 2008.

References 

  1. Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dijkman JH, Sterk PJ. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med. 1992;327:1198–1203
  2. Haney S, Hancox RJ. Rapid onset of tolerance to beta-agonist bronchodilation. Respir Med. 2005;99:566–571
  3. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med. 1997;337:1405–1411
  4. Hancox RJ, Taylor DR. Long-acting beta-agonist treatment in patients with persistent asthma already receiving inhaled corticosteroids. BioDrugs. 2001;15:11–24
  5. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med. 2001;164:1392–1397
  6. Schwinn DA, Leone BJ, Spahn DR, Chesnut LC, Page SO, McRae RL, et al. Desensitization of myocardial beta-adrenergic receptors during cardiopulmonary bypass. Evidence for early uncoupling and late downregulation. Circulation. 1991;84:2559–2567
  7. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150:76–85
  8. Wohlsen A, Martin C, Vollmer E, Branscheid D, Magnussen H, Becker WM, et al. The early allergic response in small airways of human precision-cut lung slices. Eur Respir J. 2003;21:1024–1032
  9. Guillot C, Fornaris M, Badier M, Orehek J. Spontaneous and provoked resistance to isoproterenol in isolated human bronchi. J Allergy Clin Immunol. 1984;74:713–718
  10. Penn RB, Panettieri RA, Benovic JL. Mechanisms of acute desensitization of the beta2AR-adenylyl cyclase pathway in human airway smooth muscle. Am J Respir Cell Mol Biol. 1998;19:338–348
  11. Finney PA, Belvisi MG, Donnelly LE, Chuang TT, Mak JC, Scorer C, et al. Albuterol-induced downregulation of Gsalpha accounts for pulmonary beta(2)-adrenoceptor desensitization in vivo. J Clin Invest. 2000;106:125–135
  12. Mak JC, Hisada T, Salmon M, Barnes PJ, Chung KF. Glucocorticoids reverse IL-1beta-induced impairment of beta-adrenoceptor-mediated relaxation and up-regulation of G-protein-coupled receptor kinases. Br J Pharmacol. 2002;135:987–996
  13. Chong BT, Agrawal DK, Romero FA, Townley RG. An in vivo model of beta-adrenoceptor desensitization. J Pharmacol Toxicol Methods. 1998;40:109–115
  14. Mak JC, Nishikawa M, Barnes PJ. Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung. Am J Physiol Lung Cell Mol Physiol. 1995;268:L41–L46
  15. Kaur M, Chivers JE, Giembycz MA, Newton R. Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells. Mol Pharmacol. 2008;73:203–214
  16. Mak JC, Nishikawa M, Shirasaki H, Miyayasu K, Barnes PJ. Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo. J Clin Invest. 1995;96:99–106
  17. Aziz I, Lipworth BJ. A bolus of inhaled budesonide rapidly reverses airway subsensitivity and beta2-adrenoceptor down-regulation after regular inhaled formoterol. Chest. 1999;115:623–628
  18. Fraser CM, Venter JC. The synthesis of beta-adrenergic receptors in cultured human lung cells: induction by glucocorticoids. Biochem Biophys Res Commun. 1980;94:390–397

 Supported by HL080676, HL064063, HL081824, and ES013508.

 Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.

PII: S0091-6749(08)01375-4

doi: 10.1016/j.jaci.2008.07.040

The Journal of Allergy and Clinical Immunology
Volume 122, Issue 4 , Pages 734-740 , October 2008